Andrew Deavin

Senior Director, Global Regulatory Affairs at GSK

Speaker

Andrew Deavin has spent over 25 years in Regulatory Affairs operating in the UK, Europe and International, after having gained a M.Sc. and Ph.D. in Immunology and working in vaccine research. He has managed regulatory projects in development, registration and life-cycle primarily in vaccines but also in haematology/oncology. Andrew has worked both in European Regulatory Affairs and in International for vaccine products in strategy and issue resolution. He is currently in Regulatory Policy working externally to reduce complexity in the regulatory environment and enhance access of innovative vaccine products. This includes active involvement in various industry associations and is an experienced external presenter on various regulatory topics. Amongst various external activities, Andrew is Co-Chair of Vaccines Europe Regulatory Affairs Working Group and is part of EMA’s Focus group on Regulatory Reliance. Andrew is GSK’s Global Policy Lead supporting Vaccines as well as Regulatory Policy Lead for GSK products in Greater China and Intercontinental region (which includes China, Japan, Korea and Canada). Andrew is currently based in Belgium.